Ety Klinger, Chief  R&D officer at MediWound

Ety Klinger

Chief R&D officer at MediWound | Israel

Profile last verified May 2026
Pharmaceuticals Verified Profile Israel Northwestern University - Kellogg - Recanati School of Management
Verified

Work Email

***@mediwound.com

Last verified May 2026

Personal Email

***@proteologics.com

Personal • High Confidence

Phone Number

+97*****

Israel • Mobile

Free account · No credit card · 5 profiles/month

Ety Klinger Socials
Ety Klinger Work Experience

Vp R&D at Proteologics in July 2011 - Present

Resting at Home in January 2014 - Present

Chief R&D officer at MediWound in May 2014 - Present

See more See less

Senior Director , Innovative R&D at Teva Pharmaceuticals in June 2008 - August 2011

Senior Director at Teva Pharmaceutical Industries Ltd. in January 2006 - December 2008

Head of development MS and AI diseases at Teva Pharmaceutical Industries Ltd. in June 2006 - June 2008

Ety Klinger Education

Northwestern University - Kellogg - Recanati School of Management, June 2026

Tel Aviv University, Ph.D, June 1989 to June 1994

Tel Aviv University, Ph.D, June 1988 to June 1993

See more See less

The Hebrew University, Bachelor of Science (BSc), June 1982 to June 1985

Ety Klinger Skills
Biotechnology Pharmaceutical Industry R&D Lifesciences Clinical Development Regulatory Affairs Medical Devices FDA Drug Development Clinical Trials Technology Transfer Drug Discovery Cross-functional Team Leadership Hardware Diagnostics Immunology Product Launch Biopharmaceuticals Cancer GMP Commercialization Oncology Validation Regulatory Submissions GLP Drug Delivery Protein Chemistry Chromatography In Vitro Biochemistry Sop Assay Development Molecular Biology Cell CRO Life Sciences Cell Biology SOP Research and Development (R&D) Strategic Partnerships U.S. Food and Drug Administration (FDA)
About Ety Klinger’s Current Company
MediWound

MediWound Ltd. (Nasdaq: MDWD) is a global biotechnology company focused on developing and commercializing enzymatic therapies for non-surgical tissue repair. The company’s FDA-approved biologic, NexoBrid®, is indicated for the enzymatic removal of eschar in thermal burns and is marketed in the U.S., European Union, Japan, and other international markets. MediWound is also advancing EscharEx®, a late-stage investigational therapy for the debridement of chronic wounds. EscharEx has demonstrated clinical advantages over the leading enzymatic debridement product and targets a substantial global market opportunity.

Discover more about MediWound
Ety Klinger’s Colleagues
Igor Visnadul

Igor Visnadul

Israel

IT QA Manager | Project Manager

Information Technology Quality Assurance Manager at MediWound
(March 2024 – Present)

KZ

Keren Zarbiv

Netherlands

Global RA and Clinical Development Strategy

Director of Global Regulatory Affairs, Non-Clinical and Clinical Development at MediWound
(August 2025 – Present)

Heli Ashkenazi

Heli Ashkenazi

Center District, Israel

Corporate Controller | Finance Manager | CPA

• Directing the financial structure in Israel and Germany.
• Managing teams of global bookkeepers and Controllers.
• Fostering the team by training, supervising, and professional mentoring, while ensuring quality and compliance with regulatory standards.
• Collaborati...

Barry Wolfenson

Barry Wolfenson

Philadelphia, Pennsylvania, United States

EVP, Strategy & Corporate Development, MediWound

Board Of Directors at SANO Diagnostics
(Feb 2017 – Present)

Gary Coakley-harding

Gary Coakley-harding

Greater Liverpool Area

Business Unit Manager UK, Ireland & Nordic Region, MediWound Germany GmbH Email : [email protected] Twitter : @MediwoundU

Business Unit Manager UK Ireland & Nordic Region at MediWound
(Dec 2023 – Present)

Liron Gal

Liron Gal

Rehovot, Center District, Israel

VP Manufacturing Science and Technology@MediWound | Ph.D. in Molecular Genetics

University Lecturer at Hebrew University of Jerusalem. Robert H. Smith Faculty of Agriculture, Food and Environment
(Oct 2020 – Present)

Search similar profiles
Frequently asked questions about Ety Klinger

What is Ety Klinger email address?

Email Ety Klinger at [email protected] and [email protected]. This email is the most updated Ety Klinger's email found in 2026.

How to contact Ety Klinger?

To contact Ety Klinger send an email to [email protected] or [email protected]. (updated on December 27, 2025)

What company does Ety Klinger work for?

Ety Klinger works for MediWound.

What is Ety Klinger's role at MediWound?

Ety Klinger is Chief R&D officer

What industry does Ety Klinger work in?

Ety Klinger works in the Pharmaceuticals industry.

Engage candidates 10x faster

Enjoy unlimited access and discover candidates outside of LinkedIn

Trusted by 1.4M users from 76% of Fortune 500 companies

Microsoft Tenstorrent Merck Rackspace WarnerMedia Societe Generale Yelp Google

The most accurate data ever

CCPA Compliant
GDPR Compliant
150M Personal Emails
200M Work Emails
100M Direct Dials
250M Professional Profiles
40M Company Profiles

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free